The global botulinum toxin market size is valued at USD 8.97 billion by 2028, growing at a CAGR of 7.8%

Botox market size, growth is driven by increase in cosmetic procedures, use of botulinum toxin, and increasing number of non-invasive cosmetic procedures.The botulinum toxin type A segment is expected to grow at the highest CAGR during 2021-2028.
NEW YORK, March 16, 2022 /PRNewswire/ — The Insight Partners has published a report on “Botulinum Toxin Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type (Botulinum Toxin A and Meat botulinum toxin B), applications (medical and cosmetic), and end users (specialty and dermatology clinics, hospitals and clinics, etc.)”, the global botulinum toxin market is expected to grow from USD 5.3 billion in 2021 by 2028 to $8.97 billion.It is expected to grow at a CAGR of 7.8% from 2021 to 2028.
United States, United Kingdom, Canada, Germany, France, Italy, Australia, Russia, China, Japan, Korea, Saudi Arabia, Brazil, Argentina
In 2019, for example, UK government authorities launched a campaign about botched cosmetic procedures and their impact on people’s physical and mental health.In addition, some manufacturers are working to provide more advanced non-invasive cosmetic treatment products.
The growth of the botulinum toxin market is attributed to the product and technology development by companies in the botulinum toxin field in the country.Botulinum toxin was first licensed for use in neuromuscular diseases by intramuscular injection in the European Union in 1994.The biological and pharmacological characterization of botulinum toxin (BT) has been an exciting topic of research in medical science.Interestingly, it is the first biological toxin to enter disease biology, opening up many new opportunities for healthcare companies.Next-generation sequencing technology has helped advance the field of botulinum toxin (BT).
Among the different subtypes of botulinum toxin, subtype A for botulinum neurotoxin therapy has received a lot of attention from players due to its excellent safety profile and potential for injectable and oral dosage forms.
By product type, the global botulinum toxin market is segmented into botulinum toxin type A and botulinum toxin type B.The botulinum toxin type A segment accounted for the largest market share in 2021 and is expected to witness the highest CAGR in the market during the forecast period.On the basis of application, the botulinum toxin market is segmented into medical and cosmetic.In 2021, the medical segment will occupy the largest market share.The highest CAGR is expected from 2021 to 2028.The factor behind this growth is the growing global demand for diagnosing various medical conditions.
By end user, the market is segmented into specialty and dermatology clinics, hospitals, and clinics, and others.In 2021, the specialist and dermatology clinic segment leads the market.The highest CAGR is expected from 2021 to 2028.
A large portion of the population, including those over 40, is concerned with appearance and wants to stay young.Hence, the increasing emphasis on aesthetic features by women is likely to spur market expansion in the coming years, especially in developed countries.Additionally, Botox can treat several age-related conditions such as forehead line, glabella, crow’s feet, and more.Therefore, people over the age of 40 are prone to these signs of aging.As a result, Botox procedures are becoming increasingly important in the 40-54 age group, increasing market value.These are the key factors expected to drive the botulinum toxin market over the forecast period.
Buy Premium Copy of Botulinum Toxin Market Size, Share, Revenue, Strategic Insights and Forecast 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00027431/
On the basis of product type, the global botulinum toxin market is segmented into botulinum toxin type A and botulinum toxin type B.The botulinum toxin type A segment accounted for the largest market share in 2021 and is expected to witness the highest CAGR in the market during the forecast period.Botulinum toxin type A is a purified form used to block the release of acet


Post time: Mar-31-2022